Identification of a novel therapeutic agent for Inflammatory Bowel Disease guided by systems medicine
Katie Lloyd, Stamatia Papoutsopoulou, Emily Smith…·Michael David Burkitt
This study identifies clarithromycin as a potential therapeutic for inflammatory bowel disease through in-silico drug repositioning and experimental validation of its effects on NF-κB signaling.